DLK1 and cancer: DLK1-positive sub-populations have also been reported to express stem cell and progenitor cell markers (Nanog, Oct3/4, SOX2) and exhibit cancer stem cell–like characteristics, including resistance to chemotherapeutic agents [7,18].